Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on VALNEVA mainly cover M&A activity, earnings publications et guidance and outlook. The stock trades at €2,11 on Euronext Paris, up 1,34% at the last update. This page lists the articles published on VALNEVA stock to track the share price, company announcements and any item likely to influence market perception.
The Lyon-based biotech specializing in vaccines marks one of the sharpest rebounds in the index this Monday, in an overall well-oriented Parisian mark…
The Lyon-based biotech specializing in vaccines is among the biggest losers on the SBF 120 at midday, even as the index moves higher. The stock is plu…
The Lyon-based biotech specializing in vaccines is regaining ground during the session, in a slightly bullish SBF 120. The stock is attempting a recov…
The Lyon-based biotech company is regaining some ground after several weeks of decline. The stock is attempting a technical recovery even as the SBF 1…
On Thursday, the Lyon-based biotech continues its decline while the SBF 120 sees a slight increase. The stock breaks a new technical threshold and is …
The Lyon-based biotech continues to lose ground in a downward-trending SBF 120. The stock has broken through a closely-watched technical threshold and…
Midday sees the Lyon-based biotech extending its downturn, as the SBF 120 also trends negatively. The stock is sinking into a technically fragile zone…
The Lyon-based biotech company experiences another session in the red, amidst a slightly bearish SBF 120. The stock is sinking below key technical lev…
The Lyon-based biotech specializing in vaccines continues to decline during the session, in an otherwise well-oriented SBF 120. The stock is sinking i…
The Lyon-based biotech specializing in vaccines declines during the session, amidst a slightly bullish SBF 120. The stock continues to operate in a fr…
